P&O Insights: International Exchange on Spina Bifida
OTWorld is continuing its successful collaboration with the American Academy of Orthotists & Prosthetists (AAOP) in the form of a transnational symposium. The focus this year will be on the topic of spina bifida. Prominent experts from the US and Germany will be presenting innovative approaches and modern treatment
The transnational symposium will be held this year for the third time. The foundations of this collaborative venture were laid in 2019 when the "OTWorld Congress – P&O Insights" format was introduced as a way of intensifying global knowledge transfer in the field of technical orthopaedics.
The next event is scheduled for 8 March 2024 in Chicago as part of the 50th AAOP Annual Meeting and is entitled Modern Treatment and Innovations for the Patient with Spina Bifida – US-German Exchange: Pediatric O&P. International experts including Gregory Heuer and Danielle D'Amico (Children's Hospital of Philadelphia), Dipl.-Ing. Merkur Alimusaj (Universitätsklinikum Heidelberg) and Prof Frank Braatz (UMG/HAWK University Medical Centre in Göttingen) will be at the symposium to take an in-depth look at caring for patients with spina bifida. Lauren Levey (Boston Orthotics & Prosthetics) will be leading the symposium in Chicago.
This scientific exchange will then be continued at OTWorld 2024 in Leipzig. On 15 May 2024, Dipl.-Ing. Merkur Alimusaj and Lauren Levey will chair a symposium under the same title: Modern Treatment and Innovations for the Patient with Spina Bifida – US-German Exchange: Pediatric O&P. From 3:15 to 4:30 pm, speakers in Leipzig including Dr Gregory Heuer, Prof Frank Braatz and Prof Stephan Martin (Diakovere Annastift Orthopaedic Hospital in Hannover) will share their insights into the latest developments and research findings.
The continued collaboration between OTWorld and the AAOP underlines the commitment of both organisations to the global exchange of best practices in technical orthopaedics with the aim of achieving groundbreaking advances in treating patients with spina bifida.
